Digging into phenotype change in mismatch repair deficient endometrial carcinoma and treatment with immune checkpoint inhibition, a case report

Digging into phenotype change in mismatch repair deficient endometrial carcinoma and treatment with immune checkpoint inhibition, a case report

Bibliographic Details
Main Authors:	Macarena Rey-Cárdenas, Lucia Parrilla-Rubio, Luis Manso, Rodrigo Sanchez-Bayona, Carmen Alvarez-Conejo, Ainhoa Madariaga
Format:	Article
Language:	English
Published:	Elsevier 2023-10-01
Series:	Gynecologic Oncology Reports
Subjects:	Endometrial carcinoma Deficient MMR Microsatellite instability Immunotherapy RESPONSE biomarker
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352578923002953

Similar Items

Activity of pembrolizumab and lenvatinib in mismatch repair deficient (dMMR) endometrial cancer patients who have failed pembrolizumab monotherapy: A case series
by: Peter G. Rose, et al.
Published: (2023-12-01)

Complete response to pembrolizumab in a patient with dermatomyositis and MMR deficient ovarian cancer: A case report
by: Maia L. Valls, et al.
Published: (2022-06-01)

Long-Term Survival and Clinicopathological Implications of DNA Mismatch Repair Status in Endometrioid Endometrial Cancers in Hong Kong Chinese Women
by: Jacqueline Ho Sze Lee, et al.
Published: (2021-10-01)

Screening of Lynch syndrome in endometrial cancer in Iranian population with mismatch repair protein by immunohistochemistry
by: Somayyeh Noei Teymoordash, et al.
Published: (2022-09-01)

COMBINATION OF LENVATINIB AND PEMBROLISUMAB IN THE TREATMENT OF ADVANCED ENDOMETRIAL CANCER: A CASE REPORT
by: O. N. Churuksaeva, et al.
Published: (2021-03-01)

Durable Clinical Benefit after Dual Checkpoint Inhibition and Single-agent Nivolumab Following Pembrolizumab Failure in Mismatch Repair-deficient Colon Cancer
by: Yat-Fung Chow, et al.
Published: (2023-10-01)

Performance of the Idylla microsatellite instability test in endometrial cancer
by: Marta Mendiola, et al.
Published: (2024-10-01)

Pathogenic Insights into DNA Mismatch Repair (MMR) Genes–Proteins and Microsatellite Instability: Focus on Adrenocortical Carcinoma and Beyond
by: Mara Carsote, et al.
Published: (2023-05-01)

Stage-dependent prognostic shift in mismatch repair-deficient tumors: Assessing patient outcomes in stage II and III colon cancer
by: Kjersti Elvestad Hestetun, et al.
Published: (2022-08-01)

Case Report: Life-threatening hypercalcemia associated with MMR-deficient endometrial carcinoma secreting parathyroid hormone
by: Huazhen Liu, et al.
Published: (2023-01-01)

Microsatellite instability as a reliable marker of coexisting endometrial cancer in atypical endometrial hyperplasia
by: А. E. Protasova, et al.
Published: (2024-07-01)

De-Escalated Adjuvant Treatment for Advanced MMR Deficient Mixed Endometrioid/Clear Cell Endometrial Carcinoma with PD-1 Inhibition Alone: A Case Report
by: Danielle M. Blemur, et al.
Published: (2024-08-01)

Impact of microsatellite instability on survival of endometrial cancer patients
by: Daiva Kanopienė, et al.
Published: (2014-01-01)

A retrospective study of consistency between immunohistochemistry and polymerase chain reaction of microsatellite instability in endometrial cancer
by: Cheng Wang, et al.
Published: (2023-08-01)

Clinicopathological characteristics of high microsatellite instability/mismatch repair-deficient colorectal cancer: A narrative review
by: Wei-Jian Mei, et al.
Published: (2022-12-01)

All three MutL complexes are required for repeat expansion in a human stem cell model of CAG-repeat expansion mediated glutaminase deficiency
by: Bruce Hayward, et al.
Published: (2024-06-01)

DNA Mismatch Repair Proteins and BRAF V600E Detection by Immunohistochemistry in Colorectal Cancer Demonstrates Concordance with Next Generation Sequencing
by: Joel Yambert, et al.
Published: (2022-12-01)

Microsatellite instability and mismatch repair protein deficiency: equal predictive markers?
by: Maja L. Nádorvári, et al.
Published: (2024-04-01)

Organoids and metastatic orthotopic mouse model for mismatch repair-deficient colorectal cancer
by: Yurong Song, et al.
Published: (2023-09-01)

The Roles of TP53 and FGFR2 in Progress Made Treating Endometrial Cancer
by: Olga Adamczyk-Gruszka, et al.
Published: (2022-07-01)

Treatment patterns and real-world clinical outcomes in patients with advanced endometrial cancer that are non-microsatellite instability high (non-MSI-high) or mismatch repair proficient (pMMR) in the United States
by: Sneha S. Kelkar, et al.
Published: (2022-08-01)

Endometrial Carcinoma: Immune Microenvironment and Emerging Treatments in Immuno-Oncology
by: Sandrine Rousset-Rouviere, et al.
Published: (2021-06-01)

Low frequency of mismatch repair deficiency in gallbladder cancer
by: Benjamin Goeppert, et al.
Published: (2019-05-01)

Resistance to immune checkpoint inhibitors in colorectal cancer with deficient mismatch repair/microsatellite instability: misdiagnosis, pseudoprogression and/or tumor heterogeneity?
by: Nicola Normanno, et al.
Published: (2024-05-01)

Microsatellite instability in endometrial cancer: the role of diagnostic methods and their clinical application. Expert consensus
by: A. S. Tyulyandina, et al.
Published: (2023-05-01)

A noninvasive nomogram model based on CT features to predict DNA mismatch repair deficiency in gastric cancer
by: Jie-Yu Chen, et al.
Published: (2023-03-01)

Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours
by: Birgit S. Geurts, et al.
Published: (2023-03-01)

Comparison of standard mismatch repair deficiency and microsatellite instability tests in a large cancer series
by: Maja L. Nádorvári, et al.
Published: (2024-02-01)

Mismatch repair deficiency in bilateral breast cancer
by: Milena Massumi Kozonoe, et al.
Published: (2024-08-01)

Efficient sequence of therapy for advanced and metastatic endometrial cancer
by: A. A. Rumyantsev
Published: (2022-09-01)

Single-cell AI-based detection and prognostic and predictive value of DNA mismatch repair deficiency in colorectal cancer
by: Marta Nowak, et al.
Published: (2024-09-01)

The prevalence of DNA microsatellite instability in anaplastic thyroid carcinoma – systematic review and discussion of current therapeutic options
by: Maria Linda Rocha, et al.
Published: (2021-10-01)

Microsatellite Instability in Ovarian Invasive and Borderline Epithelial Tumors and Comparison with Prognostic Parameters
by: Filiz İlhan Türkel, et al.
Published: (2020-10-01)

Microsatellite Instability and MMR Genes Abnormalities in Canine Mammary Gland Tumors
by: Faiz Muhammad Khand, et al.
Published: (2020-02-01)

The distinct clinical trajectory, metastatic sites, and immunobiology of microsatellite-instability-high cancers
by: Shuting Han, et al.
Published: (2022-12-01)

Mismatch repair deficiency testing in Lynch syndrome-associated urothelial tumors
by: Maria Rasmussen, et al.
Published: (2023-04-01)

Consistency analysis of mismatch repair protein expression and microsatellite stability in colorectal cancer
by: ZHU Hui, CAI Jidong, LI Minghan, YANG Wentao, XU Ye
Published: (2024-03-01)

Assessment of Immune Status in Patients with Mismatch Repair Deficiency Endometrial Cancer
by: Ma J, et al.
Published: (2024-04-01)

Microsatellite Instability and Its Clinical Significance in Endometrial Carcinoma
by: XIAO Jing, WU Ying
Published: (2022-01-01)

Combination of pembrolizumab and lenvatinib in second-line therapy for MSS/pMMR advanced endometrial cancer: literature review and a case report
by: A. D. Darenskaya, et al.
Published: (2024-01-01)